Purpose A fixed-dose combination of a stain and an antihypertensive drug may be useful for
the treatment of patients with hypertension and hyperlipidemia. It may also improve patient …

Introduction Hypertension and hypercholesterolaemia are important contributors to the
development and progression of atherosclerosis. The coexistence of these two conditions is …

Purpose Coexistence of hypertension (HTN) and hypercholesterolemia is a major
synergistic and modifiable risk factor for cardiovascular disease (CVD). Thus, a fixed-dose …

Purpose Dyslipidemia and hypertension increase the risk for cardiovascular disease.
Combination therapy improves patient compliance. This study was conducted to compare …

Purpose The aim of this study was to evaluate the blood pressure–lowering and cholesterol-
lowering effects of a fixed-dose combination therapy using candesartan (CND)/rosuvastatin …

Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the
development and severity of cardiovascular disease. Treatment goals may be more …

Purpose Fixed-dose combination therapy with telmisartan, amlodipine, and rosuvastatin is
needed in patients with hypertension and dyslipidemia for better adherence and cost …

Abstract This multicenter, phase 4, Prospective Randomized Open, Blinded End‐point
(PROBE) study aimed to evaluate safety and efficacy of telmisartan/rosuvastatin single‐pill …

BACKGROUND: Hypertension guidelines recommend the use of 2 agents with synergistic
action when> 1 agent is needed to achieve blood pressure goals. Newer antihypertensive …

Background The concurrent administration of statins and antihypertensive agents has been
associated with improved cardiovascular outcomes, although the optimal fixed-dose …